547,497 results on '"SARS-coV-2"'
Search Results
52. Humoral and cellular response to SARS-CoV-2 mRNA vaccine in paediatric heart transplant recipients
53. Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 omicron subvariant during pregnancy - A case series study
54. Molecular characteristics of organic matters in PM2.5 associated with upregulation of respiratory virus infection in vitro
55. Wastewater based measures of COVID-19 and associations with children's absenteeism at grade schools
56. Wastewater monitoring - passive sampling for the detection of SARS-CoV-2 and antibiotic resistance genes in wastewater
57. A multivariate analysis to explain residue errors in pathogen concentration in wastewater-based epidemiology
58. Targeting viral suppressor of RNAi confers anti-coronaviral activity
59. The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity
60. Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene
61. HLA-DQB1*05:03 is associated with an increased risk of COVID-19 progression in the Bulgarian population
62. Evaluation of anti-SARS-CoV-2 RBD antibody response after booster dose of SpikoGen® in individuals with two previous doses of Sinopharm and its association with HLA-DR and -DQ alleles
63. Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trial
64. Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform
65. Effect of immunoadsorption on clinical presentation and immune alterations in COVID-19–induced and/or aggravated ME/CFS
66. Combination of spatial transcriptomics analysis and retrospective study reveals liver infection of SARS-COV-2 is associated with clinical outcomes of COVID-19
67. An ultra-early, transient interferon-associated innate immune response associates with protection from SARS-CoV-2 infection despite exposure
68. Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8+ T cells
69. Long COVID: Pathophysiology, current concepts, and future directions
70. Evaluation of self-collected dried blood spots for detection of SARS-CoV-2 nucleocapsid antibodies shows low sensitivity
71. Parálisis de Bell y covid-19: estudio de cohortes de comparación histórica
72. Simultaneous detection of protein and nucleic acid biomarkers with a CRISPR-based assay
73. New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons
74. Evolving SARS-CoV-2 severity among hospital and university affiliates in Spain and Greater Boston
75. Association of SARS-CoV-2 Infection during pregnancy with placental weight and histopathologic lesions
76. Buckyballs to fight pandemic: Water-soluble fullerene derivatives with pendant carboxylic groups emerge as a new family of promising SARS-CoV-2 inhibitors
77. Glutamine metabolism is essential for coronavirus replication in host cells and in mice
78. Understanding the mental health impacts of biological disasters: Lessons from Taiwan's experience with COVID-19
79. Natural cross-reactive anti-SARS-CoV-2 antibodies in avian egg yolk
80. Immune complexome analysis reveals an autoimmune signature predictive of COVID-19 severity
81. Pellino-1, a therapeutic target for control of SARS-CoV-2 infection and disease severity
82. Prompt engineering-enabled LLM or MLLM and instigative bioinformatics pave the way to identify and characterize the significant SARS-CoV-2 antibody escape mutations
83. Higher frequency of interstate over international transmission chains of SARS-CoV-2 virus at the Rio Grande do Sul - Brazil state borders
84. Recognizing SARS-CoV-2 infection of nasopharyngeal tissue at the single-cell level by machine learning method
85. Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study
86. Nirmatrelvir/ritonavir treatment and risk for postacute sequelae of COVID-19 in older Singaporeans
87. COVID-19 in patients with multiple sclerosis—A narrative review
88. Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
89. LC-Q-TOF-MS phenolic profiling, data mining for antiviral compounds, and in silico analysis against SARS-CoV-2 in heritage-pigmented rice metabolome
90. Safety and durability of the immune response after vaccination with the heterologous schedule of anti-COVID-19 vaccines SOBERANA®02 and SOBERANA® Plus in children 3–18 years old
91. Disinfection effect of ozonated water on SARS-CoV-2 in the presence of salivary proteins
92. Risks of major arterial and venous thrombotic diseases after hospitalisation for influenza, pneumonia, and COVID-19: A population-wide cohort in 2.6 million people in Wales
93. Epidemiology and response to the COVID-19 pandemic in the Dadaab Refugee Camp Complex, Kenya, March 2020–December 2022
94. Synergistic effect of probiotics and postbiotics on reducing cytokine storm, lung dysfunction, and immune escape phenomenon caused by SARS-CoV-2 infection
95. Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4′-fluorouridine
96. Real-world assessment of reinfection with SARS-CoV-2: Implications for vaccines
97. Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicity
98. Assessment of SARS-CoV-2 exposure in exotic pets in Spain
99. The rights and interests of participants as limits to clinical trials
100. Pharmacological effect of cepharanthine on SARS-CoV-2–induced disease in a Syrian hamster model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.